Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $36.0 million.

  • Genmab A's Share-based Compensation rose 3333.33% to $36.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $128.0 million, marking a year-over-year increase of 2190.48%. This contributed to the annual value of $128.0 million for FY2025, which is 2190.48% up from last year.
  • Latest data reveals that Genmab A reported Share-based Compensation of $36.0 million as of Q4 2025, which was up 3333.33% from $34.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Share-based Compensation ranged from a high of $36.0 million in Q4 2025 and a low of $24.0 million during Q1 2024